Cargando…
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
The main aim was to evaluate changes in urea cycle enzymes in NAFLD patients and in two preclinical animal models mimicking this entity. Seventeen liver specimens from NAFLD patients were included for immunohistochemistry and gene expression analyses. Three-hundred-and-eighty-two biopsy-proven NAFLD...
Autores principales: | Gallego-Durán, Rocío, Ampuero, Javier, Pastor-Ramírez, Helena, Álvarez-Amor, Leticia, del Campo, Jose Antonio, Maya-Miles, Douglas, Montero-Vallejo, Rocío, Cárdenas-García, Antonio, Pareja, Mª Jesús, Gato-Zambrano, Sheila, Millán, Raquel, del Carmen Rico, María, Luque-Sierra, Amparo, Gil-Gómez, Antonio, Rojas, Ángela, Muñoz-Hernández, Rocío, García-Lozano, María, Aller, Rocío, Andrade, Raúl J., García-Monzón, Carmelo, Andreola, Fausto, Martín, Francisco, Jalan, Rajiv, Romero-Gómez, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888708/ https://www.ncbi.nlm.nih.gov/pubmed/35232986 http://dx.doi.org/10.1038/s41598-022-06614-9 |
Ejemplares similares
-
Extracellular Vesicles as Biomarkers in Liver Disease
por: Muñoz-Hernández, Rocío, et al.
Publicado: (2022) -
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022) -
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
por: Marañón, Patricia, et al.
Publicado: (2023) -
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
por: Gato, Sheila, et al.
Publicado: (2021) -
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
por: Gil-Gómez, Antonio, et al.
Publicado: (2022)